Integer Posts Strong 2025 Adjusted Results, Launches $50 Million Accelerated Buyback as Shares Jump

Overview

• Full-year revenue rose 8% to $1.854 billion, adjusted EBITDA increased 12% to $402 million, and adjusted EPS climbed 21% to $6.40, while GAAP net income from continuing operations declined 15% to $103 million.
• Cardio & Vascular led growth with sales up 17% to $1.107 billion, supported by contributions from the Precision Coating and VSi Parylene acquisitions.
• The board authorized an approximately $50 million accelerated share repurchase funded with cash and credit facility borrowings, with the final share count determined by VWAP during the repurchase period.
• Operating cash flow totaled $196 million for 2025, and total debt increased to $1.185 billion, leaving net leverage near 3.0 times adjusted EBITDA.
• Management narrowed its 2026 outlook around the prior midpoint and maintained the high end of its adjusted EPS growth range, and the shares rose 6.38% to $92 following the release.